M

Moderna

Cambridge, United States Founded 2010 NASDAQ: MRNA

About

Pioneer in mRNA therapeutics using lipid nanoparticle (LNP) delivery technology for vaccines and medicines

Company Details

Type
commercial
Employees
1000+
Funding
Public

Key Products

  • Spikevax COVID-19 Vaccine
  • mRNA Platform
Visit Website

Related Companies